26993-32-8

Basic information

• Product Name: (2E)-2-Hexadecen-1-ol
• Synonyms: (2E)-2-Hexadecen-1-ol;(E)-2-Hexadecen-1-ol
• CAS NO: 26993-32-8
• Molecular Formula: C16H32O
• Molecular Weight: 240.42468
• Product Categories: Aliphatics
• Mol File: 26993-32-8.mol
• Article Data: 13

Chemical Properties

• Melting Point: 30-31 °C(Solv: hexane (110-54-3))
• Boiling Point: 323.2±10.0 °C(Predicted)
• Appearance: /
• Density: 0.847±0.06 g/cm3(Predicted)
• Solubility: Dichloromethane, Methanol
• PKA: 14.44±0.10(Predicted)
• CAS DataBase Reference: (2E)-2-Hexadecen-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (2E)-2-Hexadecen-1-ol(26993-32-8)
• EPA Substance Registry System: (2E)-2-Hexadecen-1-ol(26993-32-8)

Safety Data

• Hazardous Substances Data: 26993-32-8(Hazardous Substances Data)

Usage

Description

(2E)-2-Hexadecen-1-ol, also known as (E)-2-Hexadecen-1-ol, is an organic compound with the chemical formula C16H32O. It is a white solid and is useful in organic synthesis due to its unique chemical structure.

Uses

Used in Organic Synthesis:
(2E)-2-Hexadecen-1-ol is used as a synthetic building block for the creation of various organic compounds. Its alkenol structure allows for a wide range of chemical reactions, making it a versatile starting material in the synthesis of complex organic molecules.
Used in Chemical Industry:
In the chemical industry, (2E)-2-Hexadecen-1-ol is used as an intermediate in the production of various chemicals, including fragrances, pharmaceuticals, and agrochemicals. Its unique structure and reactivity contribute to the development of new and innovative products.
Used in Research and Development:
(2E)-2-Hexadecen-1-ol is also utilized in research and development for the study of its chemical properties and potential applications. Its use in this context helps to expand the understanding of organic chemistry and the development of new synthetic methods and techniques.

Upstream product

• 3163-37-9 (E)-hexadec-2-enal 
• 50-00-0 formaldehyd 
• 765-13-9 pentadec-1-yne 
• 135251-95-5 (2E)-ethyl 2-hexadecenoate 
• 2833-99-0 n-2-hexadecyn-1-ol 
• 124-25-4 myristylaldehyde 
• 765-09-3 1-bromotridecane 
• 51534-33-9 1t,3-bis-methylsulfanyl-hexadec-1-ene 
• 304-59-6 Rochelle's salt 
• 112-72-1 1-Tetradecanol 

Downstream Products

• 126624-40-6 (2R,4E)-2-N-hexadecanoylamino-4-octadecen-1-ol 
• 2673-72-5 (2S,3R,E)-2-aminooctadec-4-ene-1,3-diol hydrochloride 
• 536-14-1 N-palmitoyl-D-erythro-sphingomyelin 

Relevant articles and documents

NOVEL SYNTHESIS INTERMEDIATES FOR OBTAINING DERIVATIVES OF SPHINGOSINES, CERAMIDES AND SPHINGOMYELINS WITH GOOD YIELDS

The subject matter of the present invention is the novel molecules of formulae E, E′ and F. These molecules prove to be synthesis intermediates that are very advantageous for the manufacture of derivatives of sphingosine or of ceramides functionalized in position 1, with good yields, in which R1 and R2 are fatty chains, R3 is an alkyl group and R4 is a protective group for alcohol functions. Another subject of the invention is the use of the intermediates of type F for converting same into intermediates of type G, by means of reduction in the presence of lithium borohydride. The G molecules are precursors that are known to make it possible to obtain sphingolipids or sphingomyelin.

METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS

The present invention includes methods for the synthesis of sphingomyelins and dihydrosphingomyelins. The present invention also includes methods for the synthesis of sphingosines and dihydrosphingosines. The present invention further includes methods for the synthesis of ceramides and dihydroceramides.

NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES

The present invention relates to novel compounds of formulae (I) and (II) which are useful in the prevention, treatment and diagnosis, in vivo diagnosis of diseases or disorders related to S1P receptors, in particular, in diseases which are connected to the regulatory function of sphingosine-1-phosphate (S1P) and its analogues, such as inflammation, pain, autoimmune diseases and cardiovascular diseases.